<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1411">
  <stage>Registered</stage>
  <submitdate>6/03/2001</submitdate>
  <approvaldate>6/03/2001</approvaldate>
  <actrnumber>ACTRN12606000307505</actrnumber>
  <trial_identification>
    <studytitle>Fetal intrapartum pulse oximetry to reduce operative delivery rates in the presence of a non-reassuring fetal heart rate: a multicentre randomised controlled trial (the FOREMOST trial).</studytitle>
    <scientifictitle>Fetal intrapartum pulse oximetry to reduce operative delivery rates in the presence of a non-reassuring fetal heart rate: a multicentre randomised controlled trial (the FOREMOST trial).</scientifictitle>
    <utrn />
    <trialacronym>The FOREMOST trial</trialacronym>
    <secondaryid>Perinatal Trials Registry: PTR360</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Non-reassuring fetal status during labour</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Childbirth and postnatal care</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Duration of Study: July 1999 to September 2004.
Experimental group receive conventional CTG monitoring plus fetal oxygen saturation monitoring using an internal fetal sensor.
Nellcor N-400/FS14 Monitor
Purpose: to determine whether the addition of fetal oximetry (oxygen values) to normal monitoring could help reduce the number of times caesarean sections, vacuum and forceps births were performed for concern about the well-being of the baby during labour.</interventions>
    <comparator>Control group receive conventional cardiotocograph (CTG) monitoring in labour.</comparator>
    <control>Active</control>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Operative delivery for non reassuring fetal status (NRFS)</outcome>
      <timepoint>Measured at the time of the birth of the baby</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Staff perceptions of sensor placement.</outcome>
      <timepoint>Outcome measured soon after placing the oximetry sensor.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Operative delivery for other indications; fetal/neonatal variables (Apgar scores, umbilical and venous pH).</outcome>
      <timepoint>Outcomes measured at or close to the time of birth.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Admission to Neonatal Intensive Care Unit, (hypoxic-ixchaemic encephalopathy, death).</outcome>
      <timepoint>Outcomes measured within a few days of birth.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Maternal perceptions of their experience in the research project.</outcome>
      <timepoint>Outcome measured within a few days of giving birth and again three months later.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Women in labour at &gt; or = 36 weeks gestation with a non-reasuring CTG pattern.</inclusivecriteria>
    <inclusiveminage>16</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>44</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Multiple gestation; non-vertex presentation; placenta praevia; abrnp? placenta; APH; fetal anomaly; known significant viral infection (eg HIV); contraindication to invasive fetal monitoring</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Central randomisation by phone</concealment>
    <sequence>Computerised sequence generation, block size 10-20. Stratification by previous caesarean section and hospital.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>1/07/1999</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>600</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal Brisbane and Women's Hospital, The University of Queensland,Perinatal Research Centre</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Health &amp; Medical Research Council</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Utah Foundation (UQ)</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Mayne Bequest (UQ)</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Tyco Inc (Nellcor)</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Current methods of monitoring the well-being of the unborn baby during labour often result in concern about the unborn baby's health. This leads to delivery by caesarean section, forceps, or vacuum. These babies are usually found to be healthy once born, meaning that the operation was unnecessary. In this study, when an unborn baby appears to be distressed, half of the study participants will be allocated to continue with the current monitoring of the baby's heartbeat. The other half will have a new form of monitoring, fetal oxygen saturation monitoring, added. We will then determine whether the new form of monitoring makes a difference int he number of times women need to have a caesarian section, forceps or vacuum delivery.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Brisbane &amp; Women's Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate>8/06/1997</ethicapprovaldate>
      <hrec>RWH 97/09</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Mater Mothers' Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec>382M</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Royal Women's Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec>99/38</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Royal Hospital for Women</ethicname>
      <ethicaddress />
      <ethicapprovaldate>15/02/2002</ethicapprovaldate>
      <hrec>01/243</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>University of Queensland</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec> H317</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Christine East</name>
      <address>Perinatal Research Centre
The University of Queensland
Royal Brisbane and Womens Hospital
Butterfield St
Herston QLD 4029</address>
      <phone>+61 7 36362349</phone>
      <fax />
      <email>c.east@uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Christine East</name>
      <address>Perinatal Research Centre
The University of Queensland
Royal Brisbane and Womens Hospital
Butterfield St
Herston QLD 4029</address>
      <phone>+61 7 36362349</phone>
      <fax>+61 7 36362123</fax>
      <email>c.east@uq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>